Publication date: Jul 11, 2024
Excess weight and obesity have high prevalence rates globally and are associated with significant morbidity and mortality rates. In the wake of the COVID-19 pandemic, telehealth emerged as an effective tool for promoting healthy behaviours in the management of chronic conditions. This study employed a three-month quasi-experimental design with pre- and post-intervention measurements, assessing the progress of 82 adults assigned either to an intervention group (IG) or a control group (CG). A total of 66 participants completed the study, with 33 in each group. The IG had access to a telehealth-based platform providing educational content on healthy lifestyle habits and were followed up both in-person and remotely. The CG were monitored as usual, i. e., at their primary care nurses’ discretion. The IG exhibited a statistically significant reduction in weight, BMI, and abdominal circumference, along with improved adherence to a heart-healthy diet, specifically the Mediterranean diet, and higher levels of physical activity. The nurse-led intervention (Care4US+), utilising telehealth from primary care, has proven effective in enhancing healthy behaviours and reducing cardiovascular risk factors.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | effectiveness |
| disease | IDO | intervention |
| disease | MESH | Overweight |
| disease | MESH | obesity |
| disease | MESH | morbidity |
| disease | MESH | COVID-19 pandemic |
| disease | VO | effective |
| disease | MESH | chronic conditions |
| disease | MESH | lifestyle |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | complications |
| disease | MESH | nursing diagnoses |
| disease | MESH | weight loss |
| disease | IDO | facility |
| drug | DRUGBANK | Cholesterol |
| disease | VO | population |
| drug | DRUGBANK | Ranitidine |
| drug | DRUGBANK | Methionine |
| disease | VO | device |
| disease | VO | frequency |